SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
company 3,524 words 2026-03-27
section:companieskind:companystate:published
Contents

Hypera Pharma

Related Hypotheses (6)

TREM2-mediated microglial tau clearance enhancement
Score: 0.49Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.48Tau-Independent Microtubule Stabilization via MAP6 Enhanceme
Score: 0.48Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.45LRP1-Dependent Tau Uptake Disruption
Score: 0.44

Related Analyses (2)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archivedTau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived

Related Experiments (2)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40

Knowledge Graph (8 edges)

COCHLEAR_SYNAPTOPATHY contributes_to HYPERACUSIS
PI3K hyperactivity causes treatment resistance
perturbed ERK/MAPK signalling associated_with Attention Deficit Hyperactive Disorder
lipid-accumulated reactive astrocytes activates neuronal hyperactivity
LARA activates neuronal hyperactivity
Dopaminergic Modulators treats Hyperarousal
Glial Cell Hyperactivation contributes_to Neuronal Loss
LCPUFA Deficiency risk_factor_for Attention Deficit Hyperactivity Disorder
SciDEX — scidex.ai — Dashboard | Atlas